Endothelial progenitor cells

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 79-101

  Khakoo, Aarif Y ^a   Finkel, Toren ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Angiogenesis; Cell therapy; Stem cells; Vascular biology; Vasculogenesis

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL ADHESION; CELL FUNCTION; CELL MOTILITY; CELL REGENERATION; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; ISCHEMIC HEART DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; ANTIGENS, SURFACE; BONE MARROW CELLS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HOMEOSTASIS; HUMANS; ISCHEMIA; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE THERAPY;

EID: 14544282964     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.090203.104149     Document Type: Review

References (106)

1. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6: 389-95
2. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-74
3. Folkman J. 1971. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285:1182-86
4. Folkman J. 1972. Anti-angiogenesis: new concept for therapy of solid tumors. Ann. Surg. 175:409-16
5. Rafii S. 2000. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105:17-19
6. Solovey A, Lin Y, Browne P, et al. 1997. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337: 1584-90
7. Mutunga M, Fulton B, Bullock R, et al. 2001. Circulating endothelial cells in patients with septic shock. Am. J. Respir. Crit. Care Med. 163:195-200
8. Clancy R, Marder G, Martin V, et al. 2001. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy. Arthritis Rheum. 44:1203-8
9. Segal MS, Bihorac A, Koc M. 2002. Circulating endothelial cells: tea leaves for renal disease. Am. J. Physiol. Renal Physiol. 283:F11-19
10. Kalka C, Masuda H, Takahashi T, et al. 2000. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97:3422-27
11. Kocher AA, Schuster MD, Szabolcs MJ, et al. 2001. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-36
12. Lin Y, Weisdorf DJ, Solovey A, et al. 2000. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105:71-77
13. Shi Q, Rafii S, Wu MH, et al. 1998. Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-67
14. Hill JM, Zalos G, Halcox JP, et al. 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348:593-600
15. Lyden D, Hattori K, Dias S, et al. 2001. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7:1194-201
16. McKenney JK, Weiss SW, Folpe AL. 2001. CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am. J. Surg. Pathol. 25:1167-73
17. Miettinen M, Lindenmayer AE, Chaubal A. 1994. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod. Pathol. 7:82-90
18. Ziegler BL, Valtieri M, Porada GA, et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285: 1553-58
19. Lougheed M, Moore ED, Scriven DR, et al. 1999. Uptake of oxidized LDL by macrophages differs from that of acetyl LDL and leads to expansion of an acidic endolysosomal compartment. Arterioscler. Thromb. Vasc. Biol. 19:1881-90
20. Kreipe H, Radzun HJ, Schumacher U, et al. 1986. Lectin binding and surface glycoprotein pattern of human macrophage populations. Histochemistry 86:201-6
21. Asahara T, Murohara T, Sullivan A, et al. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-67
22. Yin AH, Miraglia S, Zanjani ED, et al. 1997. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-12
23. Peichev M, Naiyer AJ, Pereira D, et al. 2000. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95:952-58
24. + cells. Br. J. Haematol. 115:186-94
25. Gehling UM, Ergun S, Schumacher U, et al. 2000. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95:3106-12
26. Hur J, Yoon CH, Kim HS, et al. 2004. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24:288-93
27. Reyes M, Dudek A, Jahagirdar B, et al. 2002. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109:337-46
28. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49
29. Urbich C, Heeschen C, Aicher A, et al. 2003. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108:2511-16
30. Rehman J, Li J, Orschell CM, et al. 2003. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-69
31. Banai S, Shweiki D, Pinson A, et al. 1994. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc. Res. 28:1176-79
32. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-57
33. Shweiki D, Itin A, Soffer D, et al. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-45
34. Carmeliet P, Ferreira V, Breier G, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-39
35. Asahara T, Takahashi T, Masuda H, et al. 1999. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18:3964-72
36. Kalka C, Tehrani H, Laudenberg B, et al. 2000. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann. Thorac. Surg. 70:829-34
37. Moore MA, Hattori K, Heissig B, et al. 2001. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann. NY Acad. Sci. 938:36-45
38. + endothelial precursor cells. Circ. Res. 88:167-74
39. Shintani S, Murohara T, Ikeda H, et al. 2001. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-79
40. Takahashi T, Kalka C, Masuda H, et al. 1999. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5:434-38
41. Natori T, Sata M, Washida M, et al. 2002. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem. Biophys. Res. Commun. 297:1058-61
42. Iwakura A, Luedemann C, Shastry S, et al. 2003. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108:3115-21
43. Strehlow K, Werner N, Berweiler J, et al. 2003. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107:3059-65
44. Aicher A, Heeschen C, Mildner-Rihm C, et al. 2003. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9:1370-76
45. 1998. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97:1440-45
46. Llevadot J, Murasawa S, Kureishi Y, et al. 2001. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest. 108:399-405
47. Vasa M, Fichtlscherer S, Adler K, et al. 2001. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103:2885-90
48. Ito H, Rovira II, Bloom ML, et al. 1999. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res. 59:5875-77
49. Capillo M, Mancuso P, Gobbi A, et al. 2003. Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin. Cancer Res. 9:377-82
50. Kollet O, Shivtiel S, Chen YQ, et al. 2003. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J. Clin. Invest. 112:160-69
51. Heissig B, Hattori K, Dias S, et al. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109:625-37
52. Levesque JP, Liu F, Simmons PJ, et al. 2004. Characterization of hematopoietic progenitor mobilization in protease deficient mice. Blood 104:65-72
53. Asahara T, Masuda H, Takahashi T, et al. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85:221-28
54. Davidoff AM, Ng CY, Brown P, et al. 2001. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin. Cancer Res. 7:2870-79
55. Moore XL, Lu J, Sun L, et al. 2004. Endothelial progenitor cells' 'homing' specificity to brain tumors. Gene Ther. 11:811-18
56. de Bont ES, Guikema JE, Scherpen F, et al. 2001. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma. Cancer Res. 61:7654-59
57. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. 2003. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-59
58. Benezra R, Rafii S, Lyden D. 2001. The Id proteins and angiogenesis. Oncogene 20:8334-41
59. Lyden D, Young AZ, Zagzag D, et al. 1999. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401:670-77
60. Ruzinova MB, Schoer RA, Gerald W, et al. 2003. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277-89
61. De Palma M, Venneri MA, Roca C, et al. 2003. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9:789-95
62. Sussman LK, Upalakalin JN, Roberts MJ, et al. 2003. Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol. Ther. 2:255-56
63. Kim HK, Song KS, Kim HO, et al. 2003. Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer. Cancer Lett. 198:83-88
64. Ikpeazu C, Davidson MK, Halteman D, et al. 2000. Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. Biol. Blood Marrow Transplant. 6:301-8
65. Orlic D, Kajstura J, Chimenti S, et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98:10344-49
66. Zhang ZG, Zhang L, Jiang Q, et al. 2002. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90:284-88
67. Askari AT, Unzek S, Popovic ZB, et al. 2003. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703
68. Norol F, Merlet P, Isnard R, et al. 2003. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood 102:4361-68
69. Yamaguchi J, Kusano KF, Masuo O, et al. 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-28
70. Rubin LL, Staddon JM. 1999. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22:11-28
71. Lusis AJ. 2000. Atherosclerosis. Nature 407:233-41
72. Dimmeler S, Haendeler J, Zeiher AM. 2002. Regulation of endothelial cell apoptosis in atherothrombosis. Curr. Opin. Lipidol. 13:531-36
73. Dimmeler S, Rippmann V, Weiland U, et al. 1997. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ. Res. 81:970-76
74. Dimmeler S, Haendeler J, Galle J, et al. 1997. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. Circulation 95:1760-63
75. Gotlieb AI, Lee TY. 1999. Endothelial repair in atherogenesis. Curr. Top. Pathol. 93:157-66
76. Walter DH, Rittig K, Bahlmann FH, et al. 2002. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105:3017-24
77. Werner N, Priller J, Laufs U, et al. 2002. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition. Arterioscler. Thromb. Vasc. Biol. 22:1567-72
78. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, et al. 2003. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108:457-63
79. Minamino T, Miyauchi H, Yoshida T, et al. 2002. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105:1541-44
80. Heeschen C, Lehmann R, Honold J, et al. 2004. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-22
81. Tepper OM, Galiano RD, Capla JM, et al. 2002. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-86
82. Vasa M, Fichtlscherer S, Aicher A, et al. 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89:e1-7
83. Eizawa T, Murakami Y, Matsui K, et al. 2003. Circulating endothelial progenitor cells are reduced in hemodialysis patients. Curr. Med. Res. Opin. 19:627-33
84. Xu Q, Zhang Z, Davison F, et al. 2003. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ. Res. 93:e76-86
85. Hillebrands JL, Klatter FA, van Dijk WD, et al. 2002. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat. Med. 8:194-95
86. Hu Y, Davison F, Zhang Z, et al. 2003. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108:3122-27
87. Simper D, Wang S, Deb A, et al. 2003. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of non-cardiac origin are enriched in transplant atherosclerosis. Circulation 108:143-49
88. Bauters C, Isner JM. 1997. The biology of restenosis. Prog. Cardiovasc. Dis. 40:107-16
89. George J, Herz I, Goldstein E, et al. 2003. Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. Arterioscler. Thromb. Vasc. Biol. 23:e57-60
90. Orlic D, Kajstura J, Chimenti S, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5
91. Fuchs S, Baffour R, Zhou YF, et al. 2001. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 37:1726-32
92. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. 2003. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107:461-68
93. Perin EC, Dohmann HF, Borojevic R, et al. 2003. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294-302
94. Kang HJ, Kim HS, Zhang SY, et al. 2004. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363:751-56
95. Hill JM, Paul JD, Powell TM, et al. 2003. Efficacy and risk of granulocyte colony stimulating factor administration in patients with severe coronary artery disease. Circulation 108:478
96. Aiuti A, Webb IJ, Bleul C, et al. 1997. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185:111-20
97. Tachibana K, Hirota S, Iizasa H, et al. 1998. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393:591-94
98. Pillarisetti K, Gupta SK. 2001. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25:293-300
99. Hill WD, Hess DC, Martin-Studdard A, et al. 2004. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 63:84-96
100. Hamano K, Nishida M, Hirata K, et al. 2001. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn. Circ. J. 65:845-47
101. Strauer BE, Brehm M, Zeus T, et al. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-18
102. Assmus B, Schachinger V, Teupe C, et al. 2002. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-17
103. Stamm C, Westphal B, Kleine HD, et al. 2003. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46
104. Tse HF, Kwong YL, Chan JK, et al. 2003. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361:47-49
105. Galinanes M, Loubani M, Davies J, et al. 2004. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. 13:7-13
106. Ozbaran M, Omay SB, Nalbantgil S, et al. 2004. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur. J. Cardiothorac. Surg. 25:342-50